CCR10/GPR2 Antibody (314305) [Janelia Fluor® 646]
Novus Biologicals, part of Bio-Techne | Catalog # FAB3478J
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-reported, Flow Cytometry
Label
Janelia Fluor 646
Antibody Source
Recombinant Monoclonal Rat IgG2A Clone # 314305
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Y3 rat myeloid cell line transfected with human CCR10
Gln8-Asn362
Accession # P46092
Gln8-Asn362
Accession # P46092
Specificity
Detect human CCR10. Stains human CCR10-transfected cells but not irrelevant transfectants.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2A
Applications for CCR10/GPR2 Antibody (314305) [Janelia Fluor® 646]
Application
Recommended Usage
CyTOF-reported
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CCR10
Alternate Names
CCR10, GPR2
Gene Symbol
CCR10
Additional CCR10 Products
Product Documents for CCR10/GPR2 Antibody (314305) [Janelia Fluor® 646]
Product Specific Notices for CCR10/GPR2 Antibody (314305) [Janelia Fluor® 646]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...